Secondary prevention of ischemic heart disease. The case for aggressive behavioral monitoring and intervention

Psychosomatics. 1993 Nov-Dec;34(6):478-84. doi: 10.1016/S0033-3182(93)71821-6.

Abstract

The hierarchy of evidence for arguing causality of a disease by any factor consists of epidemiological and, ultimately, treatment studies. The application of these criteria to chronic negative emotion as a risk factor for ischemic heart disease (IHD) is relatively new. However, controlled prospective evidence now indicates that anger, depression, and anxiety may play a major role in the genesis of IHD. And the strongest form of evidence, a controlled clinical trial that used randomly assigned subjects, exists, implicating anger as a strong predictor in the development of IHD. Resistance to the utility of this avenue of care is not based on evidence alone because widely accepted risk factors and/or treatment modalities often have less persuasive evidence, or less powerful effects, than do the emotional factors. Rather, such resistance is largely due to "paradigmatic scotomata"--conceptual difficulties for those not familiar with biopsychosocial research. Routine psychometric screening of IHD patients may provide a cost-effective means of alerting cardiologists and internists to the relatively high levels of distress among their patients.

Publication types

  • Review

MeSH terms

  • Aspirin / therapeutic use
  • Behavior Therapy*
  • Combined Modality Therapy
  • Coronary Artery Bypass
  • Female
  • Health Care Costs
  • Humans
  • Male
  • Myocardial Ischemia / prevention & control*
  • Myocardial Ischemia / surgery
  • Myocardial Ischemia / therapy
  • Risk Factors
  • Smoking / adverse effects
  • Stress, Psychological / prevention & control
  • Type A Personality

Substances

  • Aspirin